Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 1.81% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedMultiple cross-site scripting (XSS) vulnerabilities in Magento 1.2.0 and 1.2.1.1 allow remote attackers to inject arbitrary web script or HTML via (1) the username field in an admin/ request to index.php, possibly related to the login[username] parameter and the app/code/core/Mage/Admin/Model/Session.php login function; (2) the email address field in an admin/index/forgotpassword/ request to index.php, possibly related to the email parameter and the app/code/core/Mage/Adminhtml/controllers/IndexController.php forgotpasswordAction function; or (3) the return parameter to the default URI under downloader/.
Multiple cross-site scripting (XSS) vulnerabilities in Magento 1.2.0 and 1.2.1.1 allow remote attackers to inject arbitrary web script or HTML via (1) the username field in an admin/ request to index.php, possibly related to the login[username] parameter and the app/code/core/Mage/Admin/Model/Session.php login function; (2) the email address field in an admin/index/forgotpassword/ request to index.php, possibly related to the email parameter and the app/code/core/Mage/Adminhtml/controllers/IndexController.php forgotpasswordAction function; or (3) the return parameter to the default URI under downloader/.
Attacker-controlled content can reach a browser as executable script without sufficient output encoding or sanitisation.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Multiple cross-site scripting (XSS) vulnerabilities in Magento 1.2.0 and 1.2.1.1 allow remote attackers to inject arbitrary web script or HTML via (1) the username field in an admin/ request to index.php, possibly related to the login[username] parameter and the app/code/core/Mage/Admin/Model/Session.php login function; (2) the email address field in an admin/index/forgotpassword/ request to index.php, possibly related to the email parameter and the app/code/core/Mage/Adminhtml/controllers/IndexController.php forgotpasswordAction function; or (3) the return parameter to the default URI under downloader/.
Attacker-controlled content can reach a browser as executable script without sufficient output encoding or sanitisation.
An attacker operating through the affected interface may attempt exploitation when the stated preconditions are met. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting'). The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.
AV:N/AC:M/Au:N/C:N/I:P/A:NOperational remediation based on structured source evidence.
Published 25 Feb 2009 · Last source change 7 Aug 2024, 04:40 UTC · CWE-79 · Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.